<code id='E6973A8B5B'></code><style id='E6973A8B5B'></style>
    • <acronym id='E6973A8B5B'></acronym>
      <center id='E6973A8B5B'><center id='E6973A8B5B'><tfoot id='E6973A8B5B'></tfoot></center><abbr id='E6973A8B5B'><dir id='E6973A8B5B'><tfoot id='E6973A8B5B'></tfoot><noframes id='E6973A8B5B'>

    • <optgroup id='E6973A8B5B'><strike id='E6973A8B5B'><sup id='E6973A8B5B'></sup></strike><code id='E6973A8B5B'></code></optgroup>
        1. <b id='E6973A8B5B'><label id='E6973A8B5B'><select id='E6973A8B5B'><dt id='E6973A8B5B'><span id='E6973A8B5B'></span></dt></select></label></b><u id='E6973A8B5B'></u>
          <i id='E6973A8B5B'><strike id='E6973A8B5B'><tt id='E6973A8B5B'><pre id='E6973A8B5B'></pre></tt></strike></i>

          Home / comprehensive / hotspot

          hotspot


          hotspot

          author:comprehensive    Page View:646
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In